Clients in the News: Mass General, Brigham and Women’s, NYU Langone, Christiana Care

In this month’s edition of Clients in the News, we look AI being used to detect heart disease during lung cancer screenings, a new biotech incubator in New York City from New York University (NYU) Langone, and Christiana Care’s health IT partnership with Medtronic.

AI detects signs of heart disease during lung cancer screenings
Patients getting chest CT scans for lung cancer screenings can also be measured for heart disease thanks to AI, according to a new study presented at RSNA 2019 earlier this month. The research team represents a close collaboration between Massachusetts General Hospital and Brigham & Women’s Hospital in Boston. (AI in Healthcare)

NYU Langone opens NYC's largest biotech incubator
NYU Langone Health opened a 50,000-square-foot biotech incubator space in Manhattan that has attracted backing from big-name corporate sponsors including biopharma giants Bristol-Myers Squibb, Sanofi and Boehringer Ingelheim. (FierceHealthcare)

Christiana Care forms health IT partnership with Medtronic
Wilmington, Del.-based Christiana Care and Medtronic have partnered to develop and deploy medical technologies and therapies to improve patient outcomes, the organizations announced Dec. 16. (Becker’s Hospital Review)

Posted by Jana Ballinger 12/19/2019 Categories: AI Clients in the News Health IT